Table 1.

Patients’ characteristics

Case	Histology	Stage	IS	KK-LC-1 expression (TPM)	No. of missense mutations	HLA-A		HLA-B		HLA-C
pt.1	Sq	1	High	14.49	127	A*11:01	–	B*15:01	B*39:01	C*04:01	C*07:02
pt.2	Sq	2	High	7.65	24	A*24:02	A*26:03	B*15:01	B*51:01	C*07:02	C*14:02
pt.3	Adeno	3	High	2.53	357	A*24:02	A*31:01	B*40:01	B*40:03	C*03:257	–

IS (Shinohara et al20 J Immunother Cancer 2022).

Adeno, adenocarcinoma; HLA, human leukocyte antigen; IS, immune score; Sq, squamous cell carcinoma; TPM, transcripts per million.